Sihuan Pharmaceutical Hldgs

Sihuan Pharma (460 HK) Denies China Resources Approach

Event-Driven
352 Views, 13 May 2022 13:17
EXECUTIVE SUMMARY
  • Sihuan Pharmaceutical (460 HK) has shot down rumours that it is under negotiation with potential investors in respect of privatisation.
  • Reportedly SOE China Resources is in talks with Sihuan Pharma's chairman in a deal valuing the company at US$3bn or a 114% premium to the current price. 
  • The logic of a privatisation makes sense. I would not be so quick to dismiss the denial. Plus Sihuan Pharma is very cash-rich.
detail (4-minute read)
WHAT’S TRENDING
Insights
  • Trending
  • Latest
logo
Logo
Top 5%
David Blennerhassett
Pan-Asia Catalysts/Events
Quiddity Advisors
EquitiesEvent-Driven

HK Type 4 license through Ballingal Investment Advisors Ltd. I'm a highly experienced sell-side analyst with in excess... 

Zoom:
NaN%
x